Ignite Creation Date:
2025-12-24 @ 2:59 PM
Ignite Modification Date:
2026-01-24 @ 4:06 AM
Study NCT ID:
NCT05621759
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-01
First Post:
2022-11-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
Sponsor:
NYU Langone Health
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
22-00674
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None